Research programme: low molecular weight heparin triethanolamine salt - Gene Techno Science

Drug Profile

Research programme: low molecular weight heparin triethanolamine salt - Gene Techno Science

Alternative Names: GND-006; Low molecular weight heparin triethanolamine salt; Thrombosis therapeutics - Gene Techno Science

Latest Information Update: 29 Aug 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Gene Techno Science
  • Class Low molecular weight heparins
  • Mechanism of Action Thrombin inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Discontinued Cardiovascular disorders

Most Recent Events

  • 29 Aug 2016 Discontinued for Cardiovascular disorders in Japan (Topical)
  • 16 Jul 2016 No recent reports of development identified for research development in Cardiovascular-disorders in Japan (Topical)
  • 31 Mar 2015 Research programme: low molecular weight heparin triethanolamine salt - Gene Techno Science is available for licensing as of 31 Mar 2015. www.g-gts.com
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top